Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
1.
Singapore Med J ; 49(4): 346-8, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18418529

ABSTRACT

The Aeromonas species uncommonly cause disease in humans. We report portal pyaemia secondary to Aeromonas hydrophila bacteraemia occurring in a 71-year-old Chinese man with no history of hepatobiliary disease or malignancy. He presented with fever, rigors and abdominal bloating for four days and was subsequently found to have Aeromonas hydrophila bacteraemia, portal vein thrombosis and a psoas abscess. He was treated with ciprofloxacin and had a good recovery. Aeromonas hydrophila infection is an uncommon cause of intestinal and extraintestinal infection in man, but must be suspected in immunocompromised hosts and in those exposed to brackish or salt water.


Subject(s)
Aeromonas hydrophila/pathogenicity , Bacteremia/microbiology , Gram-Negative Bacterial Infections/physiopathology , Psoas Abscess/microbiology , Thrombosis , Aged , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Ciprofloxacin/therapeutic use , Gram-Negative Bacterial Infections/drug therapy , Humans , Male , Portal Vein/microbiology , Psoas Abscess/complications , Thrombosis/complications , Thrombosis/diagnostic imaging , Thrombosis/microbiology , Tomography, X-Ray Computed
2.
Travel Med Infect Dis ; 5(1): 62-3, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17161325

ABSTRACT

INTRODUCTION: Dengue fever is endemic in many countries of South East Asia. In spite of the occasional epidemics, dengue maculopathy remains a rare entity. CASE HISTORY: A 31-year-old gentleman was admitted with a 6-day history of fever, generalised rash, headache and myalgia after a trip to Malaysia. There were no bleeding manifestations. The lowest platelet count was 71 x 10,000/ml, the haematocrit was 42.7%, and dengue serology was positive. On the 8th day of illness, he complained of bilateral blurred vision. Detailed visual examination showed visual acuity of right eye 6/30 and left eye 6/50. Fundoscopy revealed dilated veins, hyperaemic optic discs, flame and blot haemorrhages, soft exudates and macular ischaemia. After a course of high-dose steroids, the visual acuity as well as colour vision improved markedly. DISCUSSION: The pathology of maculopathy is not obvious in this case, but an immunological reaction is suspected. There is a risk of residual visual impairment, and there is no definitive treatment. The use of high-dose steroids seemed to improve visual acuity and colour vision. However, it is not known whether immunosuppression improves the prognosis. Time for resolution is from 8 weeks to 4 months. Since there is an increase in the incidence of dengue fever in our region, coupled with rising international travel, one could postulate that global incidence of dengue-related maculopathy may become significant. CONCLUSION: Ocular complications associated with dengue fever are rare but may result in permanent visual impairment. Dengue fever should be suspected in travellers, particularly those returning from endemic areas, and they should be systematically screened for maculopathy when visual disturbances arise.


Subject(s)
Dengue/complications , Macula Lutea/pathology , Macula Lutea/virology , Travel , Vision Disorders/etiology , Adult , Dengue/drug therapy , Dengue/epidemiology , Humans , Malaysia , Male , Ophthalmoscopy , Steroids/therapeutic use , Treatment Outcome
3.
Singapore Med J ; 44(8): 420-2, 2003 Aug.
Article in English | MEDLINE | ID: mdl-14700422
4.
Singapore Med J ; 42(2): 85-8, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11358199

ABSTRACT

Neuroleptic malignant syndrome is an uncommon condition characterised by hyperthermia, rigidity, altered mentation and autonomic instability. Recognition of this condition is essential because its complications are potentially lethal, leading to death in 20% of patients. Not all cases of this syndrome are associated with the use of neuroleptics and there is an increasing number of reports of this condition occurring after withdrawal of therapy with dopaminergic drugs, typically in patients with Parkinsonism. In this setting, there is tremendous potential for misdiagnosis and delay in institution of treatment because of the traditional and common association of the syndrome with the use of neuroleptics only. We report a case of neuroleptic malignant syndrome in a patient with Parkinsonism subsequent to the withdrawal of levodopa and bromocriptine.


Subject(s)
Antiparkinson Agents/adverse effects , Bromocriptine/adverse effects , Levodopa/adverse effects , Neuroleptic Malignant Syndrome/diagnosis , Neuroleptic Malignant Syndrome/etiology , Parkinson Disease/drug therapy , Substance Withdrawal Syndrome/diagnosis , Substance Withdrawal Syndrome/etiology , Creatine Kinase/blood , Diagnosis, Differential , Diagnostic Errors , Drug Therapy, Combination , Female , Humans , Middle Aged , Neuroleptic Malignant Syndrome/metabolism , Substance Withdrawal Syndrome/metabolism
5.
Ann Acad Med Singap ; 30(1): 15-21, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11242618

ABSTRACT

INTRODUCTION: The purpose of this prospective study is to determine the effects of a pulmonary rehabilitation programme (PRP) conducted at our centre for patients with chronic lung disease. MATERIALS AND METHODS: Thirty-four patients (27 men and 7 women, mean age 67.7 years) with predominantly moderate-to-severe chronic obstructive pulmonary disease (31 patients), bronchiectasis (2 patients) and interstitial lung disease (1 patient) completed a 6-week outpatient PRP that included education, physical and respiratory care instruction and supervised exercise training. Outcome assessment was performed at baseline, on completion of PRP and 3 months after PRP. Physiologic measures included pulmonary function, incremental exercise and 6-minute walk tests (6MWTs). Disease-specific quality of life was assessed using the Chronic Respiratory Disease Questionnaire (CRDQ). RESULTS: There was no significant change in resting spirometry or lung volumes after PRP. Maximal oxygen uptake and work-rate improved significantly after PRP by 132.4 mL kg-1 min-1 and 10.7 W, respectively. 6MWT distance improved significantly by a mean of 67.3 m (P < 0.0001). Maximum Borg dyspnoea scores decreased significantly by 1.2 +/- 0.5 (P < 0.038). All domains of the CRDQ completed by a sub-group of patients improved significantly and the total scores increased by a mean of 21.7 points at the end of the PRP. The improvements gained in maximal exercise capacity immediately following PRP were maintained in 17 patients who returned for repeat assessment 3 months after PRP. CONCLUSION: Patients who completed a comprehensive PRP at our centre showed significant increase in functional capacity, reduction of exertional dyspnoea and improvement in health status.


Subject(s)
Exercise , Lung Diseases, Obstructive/rehabilitation , Respiratory Therapy/methods , Adaptation, Physiological , Adaptation, Psychological , Adult , Aged , Female , Humans , Lung Diseases, Obstructive/diagnosis , Lung Diseases, Obstructive/psychology , Male , Middle Aged , Prognosis , Program Evaluation , Prospective Studies , Psychology , Rehabilitation Centers , Respiratory Function Tests , Severity of Illness Index , Treatment Outcome
6.
Ann Acad Med Singap ; 29(5): 648-52, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11126703

ABSTRACT

INTRODUCTION: Accurate assessment of the exercise capacity of patients with chronic obstructive pulmonary disease (COPD) is important for the dual purpose of exercise prescription and determining response to therapy. Currently, the clinical utility of cardiopulmonary exercise testing (CPET) of patients with COPD as part of their evaluation for pulmonary rehabilitation is not established. The aims of this study were to evaluate the role of CPET in determining maximal exercise capacity and the causes of exercise limitation in patients with COPD. MATERIALS AND METHODS: The results of resting pulmonary function tests and CPET performed on 33 subjects with stable COPD as part of their evaluation for pulmonary rehabilitation were reviewed. Thirty-two of these patients had moderate or severe COPD. RESULTS: Twenty-nine of the 33 patients were able to perform maximal exercise tests during CPET. Of these 29 maximal tests, the causes of exercise limitation were ventilatory limitation in 17 patients, significant oxygen desaturation in 1 patient and both ventilatory limitation and oxygen desaturation in 11 patients. Limb muscle dysfunction is a possible limiting factor in the 4 patients with sub-maximal tests. Physical deconditioning may be a contributory factor of exercise intolerance in 2 patients. Although there was significant correlation (r = 0.597, P = 0.01) between peak VO2 percent predicted and FEV1 percent predicted, there was marked variability of peak VO2 for a given degree of airflow obstruction. CONCLUSIONS: CPET is useful for determining the causes of exercise limitation and for assessing the maximal exercise capacity of patients with COPD.


Subject(s)
Exercise Test , Exercise Tolerance , Lung Diseases, Obstructive/physiopathology , Aged , Female , Humans , Male , Middle Aged , Oxygen Consumption , Respiratory Function Tests
7.
Ann Acad Med Singap ; 29(4): 442-6, 2000 Jul.
Article in English | MEDLINE | ID: mdl-11056772

ABSTRACT

INTRODUCTION: We evaluated the results of patients with congestive heart failure (CHF) who underwent cardiopulmonary exercise testing (CPET) as part of their assessment for heart transplantation in order to examine the relationship between exercise capacity and resting indices of left ventricular function in these patients. MATERIALS AND METHODS: Twenty-seven ambulatory heart transplant candidates underwent CPET using a cycle ergometer and an incremental work-rate protocol till symptom-limitation. These patients included 24 men and 3 women with a mean age of 42.3 years. The aetiology of CHF was coronary artery disease in 14 patients, dilated cardiomyopathy in 11 patients, and congenital heart disease in 2 patients. Mean resting left ventricular ejection fraction (LVEF) was 19% (range 7% to 36%). RESULTS: Thirteen of the 27 tests performed were maximal studies and all except 2 subjects attained a measurable anaerobic threshold during CPET. Of the 13 maximal tests, the causes of exercise limitation were cardiomyopathy in 3 patients, ischaemic heart disease in 2 patients, significant oxygen desaturation in 2 patients, ventilatory limitation due to obstructive lung disease in 1 patient, ventilatory limitation secondary to a restrictive lung disease in 3 patients, and combined obstructive ventilatory and cardiovascular limitation in 2 patients. There was no significant correlation between resting LVEF and peak VO2 percent predicted (r = 0.14, P = 0.49). CONCLUSIONS: Exercise intolerance in patients with CHF may not be related to limited cardiac reserve and non-cardiac causes of exertional symptoms should also be considered. CPET is useful for the evaluation of functional capacity and mechanisms of exercise intolerance in patients with CHF.


Subject(s)
Exercise Test , Heart Failure/diagnosis , Heart Failure/surgery , Heart Transplantation , Patient Selection , Preoperative Care , Respiratory Function Tests , Adult , Exercise Test/instrumentation , Exercise Test/methods , Exercise Tolerance , Female , Heart Failure/etiology , Heart Failure/physiopathology , Humans , Male , Middle Aged , Prognosis , Respiratory Function Tests/instrumentation , Respiratory Function Tests/methods , Stroke Volume , Ventricular Function, Left , Waiting Lists
8.
Respirology ; 5(2): 99-103, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10894097

ABSTRACT

OBJECTIVE: Differing success rates of various pleurodesis agents have been reported in the management of malignant pleural effusions. A randomized clinical trial was conducted to compare the efficacy of two commonly used agents, talc and bleomycin, for the pleurodesis of malignant pleural effusions. METHODOLOGY: Inclusion in the study required proof of a malignant pleural effusion by fluid cytology or pleural biopsy. Exclusion criteria included trapped lung, loculated effusions, recurrent effusions and life expectancy < 1 month. Five grams of talc or 1 unit per kilogram bodyweight of bleomycin mixed in 150 mL of normal saline was administered via tube thoracostomy after complete drainage of the pleural effusion in each patient. Treatment success was defined as the absence of recurrent pleural effusion on the chest radiograph 1 month after pleurodesis. RESULTS: Treatment success was achieved in 16 out of 18 patients (89%) in the talc slurry group versus 14 out of 20 patients (70%) in the bleomycin group (P=0.168). Fever and pain were the only side-effects of pleurodesis in both groups. CONCLUSION: These results indicate that talc slurry is as effective as bleomycin in preventing early recurrence of malignant pleural effusions. Pleurodesis with talc instead of bleomycin can result in significant cost savings.


Subject(s)
Antibiotics, Antineoplastic/administration & dosage , Antimetabolites, Antineoplastic/administration & dosage , Bleomycin/administration & dosage , Pleural Effusion, Malignant/therapy , Pleurodesis/methods , Talc/administration & dosage , Aged , Female , Humans , Male , Middle Aged , Pleural Effusion, Malignant/pathology , Secondary Prevention , Singapore , Treatment Outcome
9.
Ann Acad Med Singap ; 29(2): 242-5, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10895347

ABSTRACT

INTRODUCTION: Patients with the upper airway resistance syndrome are frequently overlooked, and even if clinically suspected, often escape identification by polysomnographic monitoring. CLINICAL PICTURE: Three cases (2 women and a man) with excessive daytime sleepiness and fatigue were confirmed to have the upper airway resistance syndrome after undergoing polysomnography with oesophageal pressure monitoring. TREATMENT: Nasal CPAP during sleep was prescribed for 2 cases but 1 case refused all available treatment options. OUTCOME: After one month of CPAP therapy, the 2 cases reported improved symptoms and Epworth sleepiness scores. Lower daytime blood pressures were also recorded. CONCLUSIONS: Oesophageal pressure monitoring and EEG arousal analysis can greatly enhance the diagnostic accuracy in the upper airway resistance syndrome. Accurate diagnosis and effective treatment of this condition is important because of its sequelae of hypersomnolence and association with other disorders like systemic hypertension.


Subject(s)
Sleep Apnea, Obstructive/diagnosis , Electroencephalography , Female , Humans , Male , Middle Aged , Polysomnography , Prognosis , Sleep Apnea, Obstructive/physiopathology , Sleep Apnea, Obstructive/therapy , Treatment Refusal
10.
Singapore Med J ; 41(1): 19-23, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10783675

ABSTRACT

BACKGROUND: The development of a pleural effusion in a patient with a known malignancy often raises the possibility that the effusion is due to malignant involvement of the pleura. Accurate diagnosis of the cause of the pleural effusion in such a patient is essential as the treatment and prognosis may vary. Currently, thoracentesis and cytologic analysis of pleural fluid cytology is usually the initial diagnostic step. AIM: To assess the diagnostic yield of pleural fluid cytologic examination in patients with suspected malignant pleural effusions seen at our centre. METHODS: Retrospective review of the results of pleural fluid cytologic examination performed on 103 patients who presented with suspected malignant pleural effusions. RESULTS: The underlying malignancies in these patients were as follows: bronchogenic carcinoma (51.5%), breast carcinoma (29.1%), hepatocellular carcinoma (1.9%), carcinoma of the stomach (1.9%), malignant mesothelioma, nasopharyngeal carcinoma, renal cell carcinoma, carcinoma of the oesophagus, lymphoma, carcinoma of the colon (1% each), unknown (9.7%). Initial pleural fluid cytology was positive for malignancy in 48.5% of patients. The yield of this diagnostic procedure was improved with repeated pleural fluid cytologic specimens and when combined with a percutaneous pleural biopsy. There was no statistically significant difference in the clinical features and pleural fluid characteristics of patients with malignant pleural effusions and those in whom the pleural effusions were paramalignant. CONCLUSION: Pleural fluid cytologic examination is a useful initial step in the diagnostic work-up of patients with suspected malignant pleural effusions. The diagnostic yield of such examination is improved with repeated pleural fluid cytologic specimens and when combined with a percutaneous pleural biopsy. Clinical presentation and pleural fluid characteristics were inadequate in differentiating between malignant and paramalignant effusions.


Subject(s)
Pleural Effusion, Malignant/pathology , Pleural Effusion/pathology , Biopsy, Needle , Chi-Square Distribution , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Retrospective Studies , Statistics, Nonparametric
11.
Ann Acad Med Singap ; 29(1): 127-31, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10748981

ABSTRACT

INTRODUCTION: Lung volume reduction surgery (LVRS) and pulmonary rehabilitation are newer options available in the treatment of advanced emphysema. We describe the progress of our first local patient to have undergone these 2 new treatment modalities. CLINICAL PICTURE: A 65-year-old man with advanced emphysema, limited by crippling dyspnoea despite maximal medical therapy with inhaled bronchodilator therapy, methylxanthines and supplementary oxygen. TREATMENT: Physical reconditioning with a 4-week inpatient pulmonary rehabilitation programme, followed by LVRS and a further 6-week outpatient pulmonary rehabilitation. OUTCOME: Dramatic improvements in spirometric indices, arterial blood gases, exercise capacity and overall functional status. Improvements maintained at one-year follow up period. CONCLUSIONS: LVRS with pulmonary rehabilitation is an exciting new treatment option in a select group of patients with advanced emphysema. Their role in improving overall performance status and quality of life should be considered in patients otherwise considered to have reached the limits of medical therapy.


Subject(s)
Exercise Therapy , Pneumonectomy , Pulmonary Emphysema/surgery , Aged , Dyspnea/physiopathology , Dyspnea/rehabilitation , Humans , Male , Pulmonary Emphysema/rehabilitation
12.
Ann Acad Med Singap ; 28(3): 384-8, 1999 May.
Article in English | MEDLINE | ID: mdl-10575523

ABSTRACT

Patients who have survived an episode of intubation and mechanical ventilation for acute respiratory failure due to a severe and unresponsive asthmatic attack are considered to have experienced a near-fatal asthma (NFA) attack. Such patients are at a higher risk of similar severe attacks and hence of death in the future. The aims of the study were to: (i) evaluate the outcome; (ii) identify any persistent deficiencies in asthma management, and (iii) assess self-management knowledge in survivors of NFA. Ninety-three consecutive patients who had been treated for NFA in the Intensive Care Unit of an urban teaching hospital in Singapore from 1992 to 1997 were studied. All hospital records were reviewed retrospectively. Survivors were then invited to attend a questionnaire interview and to have lung function tests performed. Of the original cohort (OC) of 93 patients with NFA (mean age 55.2 years), 18 (19% OC) patients (mean age 64 years) had died while in hospital and 75 (81% OC) patients survived the initial episode of NFA and were discharged home (DH). The long-term outcome of this DH group was: 13 patients had died (17% DH) and 62 (83% DH) survived. Of these survivors, 35 were interviewed while 27 declined or were not contactable. This interview yielded the following information: (i) Hospitalisation in the past year: 66% had no hospital admission; of the 31.4% who had 2 or more admissions, most had a further NFA attack. (ii) Health care: The majority of patients (71.4%) were monitored by a single doctor. (iii) Patient knowledge of disease management was deemed good to fair for trigger avoidance (77%), for appropriate drug usage (97%). (iv) Satisfactory inhaler skill (80%). NFA is associated with a high intrahospital and long-term mortality. Although most survivors of NFA appeared to have satisfactory care and a fair understanding of medication usage, a significant minority continue to pose much morbidity and risk for death.


Subject(s)
Asthma/therapy , Aged , Asthma/mortality , Attitude to Health , Cause of Death , Female , Health Knowledge, Attitudes, Practice , Humans , Interviews as Topic/methods , Male , Middle Aged , Prospective Studies , Retrospective Studies , Singapore/epidemiology , Surveys and Questionnaires , Time Factors , Treatment Outcome
13.
Ann Acad Med Singap ; 28(2): 205-8, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10497667

ABSTRACT

In areas where tuberculosis is endemic, a positive sputum acid-fast bacilli (AFB) smear is frequently regarded as almost diagnostic of pulmonary tuberculosis (PTB). The main problem arises when the AFB smear is negative. The main aim of this study was to determine the clinical utility of rapid mycobacterial tuberculosis (MTB) detection in bronchoalveolar lavage (BAL) samples by polymerase chain reaction (PCR) in 52 patients who underwent diagnostic bronchoscopy for suspected PTB. These patients had either upper lobe infiltrates (n = 31) or bronchiectasis (n = 21). Mycobacterial culture is usually used as the gold standard of diagnosis. We chose to define active PTB based on positive mycobacterial cultures and/or histological evidence of caseous necrosis and AFB, and/or when there was clinical plus radiological improvement following therapy. We compared AFB smear, respiratory mycobacterial culture, BAL PCR for MTB and clinical active PTB. Four patients who were smear and culture negative had clinical and radiological clearance following anti-tuberculous therapy showing that using mycobacterial culture as a gold standard may have its limitations. When Kappa (a chance-corrected measure of agreement) was calculated for acid-fast bacilli smear and BAL PCR against our definition of active PTB, it was 0.28 (fair agreement) and 0.73 (substantial agreement), respectively. BAL PCR gave a sensitivity, specificity, positive and negative predictive values of 66.7%, 100%, 100% and 88%, respectively, for the group with upper lobe infiltrates. We also demonstrated that BAL for PCR has a good concordance with the final diagnosis of active tuberculosis.


Subject(s)
Bronchiectasis/microbiology , Bronchoalveolar Lavage Fluid/microbiology , Mycobacterium tuberculosis/isolation & purification , Polymerase Chain Reaction , Sputum/microbiology , Tuberculosis, Pulmonary/diagnosis , Adult , Aged , Aged, 80 and over , Antitubercular Agents/therapeutic use , Bacteriological Techniques , Bronchoscopy , Endemic Diseases , Female , Humans , Lung/pathology , Male , Middle Aged , Mycobacterium tuberculosis/genetics , Necrosis , Predictive Value of Tests , Radiography , Sensitivity and Specificity , Tuberculosis, Pulmonary/diagnostic imaging , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/pathology
14.
Ann Acad Med Singap ; 28(2): 214-6, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10497669

ABSTRACT

We studied the relationship between different ethnic groups, obstructive sleep apnoea (OSA) and ischaemic heart disease. Four hundred and thirty-two inpatients from the medical wards were interviewed. Limited overnight sleep studies were done in 129 of those who had habitual snoring, daytime sleepiness based on an Epworth sleepiness scale of 8 or more, or a large neck size of 40 cm or more. There were 315 Chinese (72.9%), 67 Malays (15.5%), 43 Indians (10%) and 3 from other races (1.4%). The prevalence of OSA was 19.7%, 30% and 12% among the Chinese, Malays and Indians, respectively. The prevalence ratio for OSA was 1.52 in Malays using Chinese patients as the baseline (P = 0.07). The median neck circumference was 37 cm in both racial groups. The median body mass index was 22.7 kg/m2 in Chinese compared to 23.6 kg/m2 in Malays. The median apnoea-hypopnoea index was 22.7, 19.0 and 26.9 events/hour among the Chinese, Malays and Indians, respectively. OSA was independently associated with the prevalence of IHD (adjusted prevalence ratio 1.68; 95% CI: 1.15, 2.46; P = 0.009). The prevalence of ischaemic heart disease (IHD) was 31%, 24% and 28% in Chinese, Malays and Indians, respectively. The prevalence ratio for IHD in Malays compared to Chinese was 0.77. After adjusting for OSA, there was an even greater reduction in the risk of IHD (adjusted prevalence ratio 0.70). This suggests that OSA is a confounder in the relationship between race and ischaemic heart disease.


Subject(s)
Ethnicity , Myocardial Ischemia/ethnology , Sleep Apnea Syndromes/ethnology , Adult , Aged , Body Mass Index , China/ethnology , Confounding Factors, Epidemiologic , Female , Humans , India/ethnology , Malaysia/ethnology , Male , Middle Aged , Neck/anatomy & histology , Prevalence , Risk Factors , Singapore , Sleep Stages , Snoring/ethnology
16.
Acta Oncol ; 38(8): 1005-9, 1999.
Article in English | MEDLINE | ID: mdl-10665753

ABSTRACT

The favourable experience with the combination regimen of vinorelbine, ifosfamide and cisplatin (NIP) in patients with metastatic non-small cell lung cancer (NSCLC) has led to a protocol assessing this regimen as an induction treatment in patients with stage III unresectable NSCLC, followed by thoracic radiotherapy with concurrent daily cisplatin as a radiosensitizer. Two cycles of NIP were administered 21 days apart; each cycle comprised i.v. vinorelbine 25 mg/m2 on days 1 and 8, i.v. ifosfamide 3 g/m2 on day 1 with MESNA as uroprotection, and i.v. cisplatin 50 mg/m2 on day 1. Radical thoracic radiotherapy commenced on day 43 to a total dose of 64 Gy and i.v. cisplatin 6 mg/m2 was given concurrently prior to each fraction of radiation as a sensitiser. Two more cycles of NIP were given to patients who responded favourably to the induction treatment about 2 weeks after completion of radiation. Between July 1995 and July 1997, 44 patients were treated with this protocol. This treatment schedule was generally well tolerated. Grade 3-4 neutropenia occurred in 50% of the patients and neutropenic sepsis was seen in 8. Grade 3-4 oesophagitis was uncommon. Most of the patients were able to complete the induction and concurrent chemoradiotherapy phase. Major response occurred in 75% of the patients with 2 (4.5%) complete responses (CR). A total of 6 patients achieved CR after chemoradiotherapy. At a median follow-up of 35 months, the median overall survival for all patients was 15 months with a 3-year survival rate of 24%. The median overall survival for stage IIIA patients was 19 months with a 3-year survival rate of 39% in contrast to 13 months' median overall survival and only 15% 3-year survival rate for stage IIIB. The NIP regimen results in a high response rate in NSCLC and this treatment programme seems to benefit selected patients with stage III disease.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Adult , Aged , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Non-Small-Cell Lung/radiotherapy , Cisplatin/administration & dosage , Combined Modality Therapy , Female , Humans , Ifosfamide/administration & dosage , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Lung Neoplasms/radiotherapy , Male , Middle Aged , Radiation-Sensitizing Agents/therapeutic use , Survival Rate , Vinblastine/administration & dosage , Vinblastine/analogs & derivatives
17.
Ann Acad Med Singap ; 27(3): 353-7, 1998 May.
Article in English | MEDLINE | ID: mdl-9777079

ABSTRACT

We studied 24 consecutive adult patients with malaria who required intensive care between 1 January 1994 and 31 December 1997. This was out of a total of 256 patients hospitalised at the Singapore General Hospital with malaria during these 4 years. Our aim was to characterise the type and severity, clinical features, complications, treatment and outcome of adult patients with malaria who required intensive care. In addition, we compared the actual and predicted mortality based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) score. The travel history, prophylaxis, duration of fever before receiving treatment, type of malaria and severity, clinical data, complications, APACHE II score, treatment and outcome were analysed. Most cases were imported by locals travelling overseas or foreigners infected with the parasite elsewhere. Four patients had vivax malaria and 20 patients had severe falciparum malaria. All but 1 patient received transfusion with blood products and 6 patients with severe falciparum malaria had exchange transfusions. Complications were restricted to infection with P. falciparum: 9 patients required acute dialysis and 8 required mechanical ventilation. Three patients died giving a mortality of 15% for severe falciparum malaria. The overall mortality of patients with malaria was 1.2%. The mortality of patients with malaria requiring intensive care was 12.5% as compared with a predicted mortality of 18.7% based on the APACHE II prognostication system.


Subject(s)
Critical Care/statistics & numerical data , Intensive Care Units/statistics & numerical data , Malaria, Falciparum/therapy , APACHE , Adolescent , Adult , Aged , Chi-Square Distribution , Critical Care/methods , Female , Humans , Incidence , Logistic Models , Malaria, Falciparum/diagnosis , Malaria, Falciparum/mortality , Male , Middle Aged , Predictive Value of Tests , Prognosis , Risk Factors , Severity of Illness Index , Singapore/epidemiology , Survival Rate
18.
Ann Acad Med Singap ; 27(3): 404-8, 1998 May.
Article in English | MEDLINE | ID: mdl-9777088

ABSTRACT

Tissue hypoxia is an important cause for the development of multisystem organ failure in the critically ill. Achieving adequate haemodynamic support of oxygen demand is the mainstay of treatment in these patients. Controversies regarding therapeutic end-points do exist but in general maintaining oxygen delivery by ensuring adequate cardiac output, oxygen saturation and haemoglobin is important in the critically ill.


Subject(s)
Critical Care/methods , Multiple Organ Failure/therapy , Oxygen/administration & dosage , Humans , Hypoxia/therapy , Oxygen Consumption , Prognosis , Treatment Outcome
19.
Eur Respir J ; 12(1): 113-5, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9701424

ABSTRACT

The aim of this study was to determine the aetiology and outcome of severe community-acquired pneumonia, and to assess whether the existing guidelines for initial antimicrobial therapy are being applied. The records of 57 consecutive nonimmunocompromised patients admitted to the medical intensive care unit (ICU) between January 1989 and May 1993 with this diagnosis were reviewed. The microbiological data, chest radiographic changes and outcome were analysed. Nine (16%) of the 57 patients had pulmonary tuberculosis. When these patients were excluded from further analysis, a microbiological diagnosis was made in 41 (72%) cases. The most commonest pathogens were Burkholderia pseudomallei (n=10), Klebsiella spp. (n=5) and Staphylococcus aureus (n=5), Mycoplasma pneumoniae (n=4) and Streptococcus pneumoniae (n=2) were less common. This microbiological spectrum was quite different from that in the West, where the incidence of S. pneumoniae was higher. Also, when pulmonary tuberculosis was excluded, the mortality (67%) was much higher than that in other series. This was attributed to the high incidence of unrecognized B. pseudomallei infection, which is associated with a very high mortality in the region under study. In addition to applying published guidelines on severe community-acquired pneumonia, the endemicity of certain organisms such as Mycobacterium tuberculosis and Burkholderia pseudomallei in different geographical regions needs to be considered when choosing initial empirical antimicrobial therapy.


Subject(s)
Community-Acquired Infections/etiology , Cross-Cultural Comparison , Pneumonia, Bacterial/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Bacteriological Techniques , Child , Community-Acquired Infections/diagnosis , Community-Acquired Infections/drug therapy , Critical Care , Diagnosis, Differential , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Pneumonia, Bacterial/diagnosis , Pneumonia, Bacterial/drug therapy , Retrospective Studies , Singapore , Sputum/microbiology , Treatment Outcome , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/drug therapy
20.
Cancer Genet Cytogenet ; 103(1): 65-7, 1998 May.
Article in English | MEDLINE | ID: mdl-9595048

ABSTRACT

A case of Waldenstrom macroglobulinemia with Burkitt-type t(8;14)(q24.1;q32) and total and partial trisomy 3 is reported. This is an unusual combination of chromosomal abnormalities in Waldenstrom macroglobulinemia.


Subject(s)
Chromosomes, Human, Pair 14/genetics , Chromosomes, Human, Pair 3/genetics , Chromosomes, Human, Pair 8/genetics , Translocation, Genetic/genetics , Trisomy/genetics , Waldenstrom Macroglobulinemia/genetics , Aged , Humans , Karyotyping , Male , Pleural Effusion/drug therapy , Pleural Effusion/genetics , Pleural Effusion/pathology , Waldenstrom Macroglobulinemia/drug therapy , Waldenstrom Macroglobulinemia/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...